• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期甲状腺恶性肿瘤的姑息治疗。

Palliation of advanced thyroid malignancies.

作者信息

Greenblatt David Yü, Chen Herbert

机构信息

Department of Surgery, Section of Endocrine Surgery, University of Wisconsin, H4/750 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792, USA.

出版信息

Surg Oncol. 2007 Dec;16(4):237-47. doi: 10.1016/j.suronc.2007.08.006. Epub 2007 Sep 14.

DOI:10.1016/j.suronc.2007.08.006
PMID:17855077
Abstract

While most thyroid cancers are slow-growing and have an excellent prognosis after appropriate treatment, a subset of thyroid cancers behave aggressively, and approximately 1500 individuals in the US will die of the disease in the year 2007. Advanced thyroid malignancies can cause distressing and life-threatening symptoms by local invasion in the neck, growth of distant metastases in the lung, bone, and other organs, and tumor production of bioactive substances in the case of medullary thyroid cancer. This article will review palliative modalities, including surgery, radioactive iodine, external beam radiation, and chemotherapy, as well as novel targeted therapies, for the treatment of patients with advanced thyroid malignancies.

摘要

虽然大多数甲状腺癌生长缓慢,经过适当治疗后预后良好,但一部分甲状腺癌具有侵袭性,2007年美国约有1500人将死于该病。晚期甲状腺恶性肿瘤可通过颈部局部侵犯、肺、骨和其他器官远处转移灶的生长以及甲状腺髓样癌中肿瘤产生生物活性物质而导致令人痛苦且危及生命的症状。本文将综述用于治疗晚期甲状腺恶性肿瘤患者的姑息治疗方法,包括手术、放射性碘、外照射放疗和化疗,以及新型靶向治疗。

相似文献

1
Palliation of advanced thyroid malignancies.晚期甲状腺恶性肿瘤的姑息治疗。
Surg Oncol. 2007 Dec;16(4):237-47. doi: 10.1016/j.suronc.2007.08.006. Epub 2007 Sep 14.
2
Management of invasive and advanced thyroid cancer.侵袭性和晚期甲状腺癌的管理
Minerva Endocrinol. 2009 Mar;34(1):37-55.
3
The role of external beam radiation and targeted therapy in thyroid cancer.外部束辐射和靶向治疗在甲状腺癌中的作用。
Semin Radiat Oncol. 2012 Jul;22(3):254-62. doi: 10.1016/j.semradonc.2012.03.010.
4
Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.伴有远处转移的甲状腺乳头状癌:生存预测因素及局部控制的重要性。
Surgery. 2008 Jan;143(1):35-42. doi: 10.1016/j.surg.2007.06.011. Epub 2007 Dec 3.
5
External beam radiation therapy for thyroid cancer.甲状腺癌的外照射放射治疗。
Endocrinol Metab Clin North Am. 2008 Jun;37(2):497-509, xi. doi: 10.1016/j.ecl.2008.02.001.
6
Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.既往辐射暴露对甲状腺癌患者病理特征及临床结局的影响。
Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):355-9. doi: 10.1001/archoto.2009.13.
7
Update on the diagnosis and therapy of distant metastases of differentiated thyroid carcinoma.分化型甲状腺癌远处转移的诊断与治疗进展
Minerva Endocrinol. 2008 Dec;33(4):313-27.
8
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.外照射放疗在晚期或复发性非间变性甲状腺癌患者中的作用:纪念斯隆凯特琳癌症中心的经验
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):795-801. doi: 10.1016/j.ijrobp.2008.05.012.
9
Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.分化型甲状腺癌放疗后的复发模式:对靶区勾画的启示
Radiother Oncol. 2008 Oct;89(1):105-13. doi: 10.1016/j.radonc.2008.05.023. Epub 2008 Jun 23.
10
Advanced lung disease: quality of life and role of palliative care.晚期肺部疾病:生活质量与姑息治疗的作用
Mt Sinai J Med. 2009 Feb;76(1):63-70. doi: 10.1002/msj.20091.

引用本文的文献

1
Notch Signaling in Thyroid Cancer. Notch 信号通路在甲状腺癌中的作用。
Adv Exp Med Biol. 2021;1287:155-168. doi: 10.1007/978-3-030-55031-8_10.
2
Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.评估乐伐替尼对放射性碘难治性分化型甲状腺癌的整体价值:一项应用实用多标准决策分析的多国研究
BMC Cancer. 2017 Apr 17;17(1):272. doi: 10.1186/s12885-017-3258-9.
3
Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer.
在一项针对进展性、放射性碘难治性分化型甲状腺癌的乐伐替尼安慰剂对照临床试验中,确定外推总生存数据的最合适方法。
Clinicoecon Outcomes Res. 2016 Jun 30;8:323-33. doi: 10.2147/CEOR.S107498. eCollection 2016.
4
Hereditary medullary thyroid cancer: age-appropriate thyroidectomy improves disease-free survival.遗传性髓样甲状腺癌:适龄甲状腺切除术可改善无病生存率。
Ann Surg Oncol. 2013 May;20(5):1451-5. doi: 10.1245/s10434-012-2757-9. Epub 2012 Nov 29.
5
Palliative and end of life care issues of carcinoma thyroid patient.甲状腺癌患者的姑息治疗和临终关怀问题
Indian J Palliat Care. 2012 May;18(2):134-7. doi: 10.4103/0973-1075.100837.
6
Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.Notch在甲状腺C细胞发育及甲状腺髓样癌治疗中的作用
Am J Transl Res. 2010 Feb 10;2(1):119-25.
7
Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.组蛋白去乙酰化酶抑制剂和氯化锂抑制甲状腺髓样癌细胞生长。
J Surg Res. 2010 Apr;159(2):640-4. doi: 10.1016/j.jss.2008.08.004. Epub 2008 Sep 4.
8
Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.互隔交链孢酚单甲醚和互隔交链孢酚通过抑制糖原合酶激酶-3β来抑制甲状腺髓样癌细胞的生长。
Mol Cancer Ther. 2009 Apr;8(4):914-20. doi: 10.1158/1535-7163.MCT-08-0712.
9
Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.丙戊酸激活Notch1信号通路并诱导甲状腺髓样癌细胞凋亡。
Ann Surg. 2008 Jun;247(6):1036-40. doi: 10.1097/SLA.0b013e3181758d0e.